We serve Chemical Name:4-Methoxystyrene CAS:637-69-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-Methoxystyrene
CAS.NO:637-69-4
Synonyms:styrene, 4-methoxy-;1-Methoxy-4-vinyl-benzene;4-VINYLANISOLE;1-Methoxy-4-vinylbenzene;MFCD00008619;4-ethenylphenyl methyl ether;Anisole, p-vinyl-;EINECS 211-298-9;UNII:2ISH8T4A6E;p-Methoxystyrene;p-vinylanisole;Methyl 4-vinylphenyl ether;Benzene, 1-ethenyl-4-methoxy-;1-ethenyl-4-methoxybenzene;1-Ethenyl-4-methoxybenzol
Molecular Formula:C9H10O
Molecular Weight:134.175
HS Code:29093090
Physical and Chemical Properties:
Melting point:3.3ºC
Boiling point:220.7±0.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.542
PSA:9.23000
Exact Mass:134.073166
LogP:2.64
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like styrene, 4-methoxy- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Ethenyl-4-methoxybenzol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-ethenylphenyl methyl ether Use and application,p-vinylanisole technical grade,usp/ep/jp grade.
Related News: In the last year alone BetterUp’s international membership increased by 151 percent, further demonstrating the global demand for strengthening mental fitness across the workforce. 7-chloro-3-methyl-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepine manufacturers UQUIFA is a manufacturer of APIs and intermediates for the pharmaceutical industry globally. The company has 3 manufacturing sites (2 in Spain and 1 in Mexico) with strict adherence to all regulatory norms. (4aR,5aR,8aR,9S,9aR)-9-Hydroxy-2,2-dimethyl-hexahydro-furo[2′,3′:5,6]pyrano[3,2-d][1,3]dioxin-7-one suppliers The FDA has already clashed with COVID vaccine heavyweights Pfizer and BioNTech over the immediate need for boosters for the broader population. While the drugmakers argue a third shot would offer the highest level of protection, both the CDC and FDA immediately came out against that assertion. (R)-napropamide vendor & factory.
